Portillo Isabel, Idigoras Isabel, Bilbao Isabel, Arana-Arri Eunate, Fernández-Landa María José, Hurtado Jose Luis, Sarasaqueta Cristina, Bujanda Luis
Colorectal Cancer Screening Programme Coordination Center, Bilbao, Spain.
BioCruces Health Research Institute, Barakaldo, Spain.
Endosc Int Open. 2018 Sep;6(9):E1149-E1156. doi: 10.1055/a-0655-1987. Epub 2018 Sep 11.
To compare the quality of colonoscopy in a population-based coordinated program of colorectal cancer screening according to type of hospital (academic or non-academic). Consecutive patients undergoing colonoscopy after positive FIT (≥ 20 ug Hb/g feces) between January 2009 and September 2016 were prospectively included at five academic and seven non-academic public hospitals. Screening colonoscopy quality indicators considered were adenoma detection rate, cecal intubation rate, complications and bowel preparation quality. A total of 48,759 patients underwent colonoscopy, 34,616 (80 %) in academic hospitals and 14,143 in non-academic hospitals. Among these cases, 19,942 (37.1 %) advanced adenomas and 2,607 (5.3 %) colorectal cancers (CRCs) were detected, representing a total of 22,549 (46.2 %) cases of advanced neoplasia. The adenoma detection rate was 64 %, 63.1 % in academic hospitals and 66.4 % in non-academic hospitals ( < 0.001). Rates of advanced adenoma detection, cecal intubation and adequate colonic preparation were 45.8 %, 96.2 % and 88.3 %, respectively, and in all cases were lower (implying worse quality care) in academic hospitals (45.3 % vs 48.7 %; odds ratio [OR] 0.87, 95 % confidence interval [CI] 0.84 - 0.91; 95.9 % vs 97 %; OR 0.48, 95 % CI 0.38 - 0.69; and 86.4 % vs 93 %; OR 0.48, 95 % CI 0.45 - 0.5; respectively; < 0.001 in all cases). In 13 patients, all in the academic hospital group, CRC was diagnosed after colonoscopy (0.26 cases × 1000 colonoscopies). Rates of CRC treated by endoscopy were similar in both types of hospital (30 %). The rate of severe complication was 1.2 % (602 patients), with no significant differences by hospital type: bleeding occurred in 1/147 colonoscopies and perforation in 1/329. One patient died within 30 days after screening colonoscopy. The quality of colonoscopy was better in non-academic hospitals. The rate of detection of advanced neoplasia was higher in non-academic hospitals and correlated with the rate of post-colonoscopy CRC.
比较在基于人群的结直肠癌筛查协调项目中,不同类型医院(学术型或非学术型)结肠镜检查的质量。2009年1月至2016年9月期间,连续5家学术型公立医院和7家非学术型公立医院对粪便免疫化学试验(FIT)阳性(≥20μg血红蛋白/克粪便)后接受结肠镜检查的患者进行前瞻性纳入。所考虑的筛查结肠镜检查质量指标包括腺瘤检出率、盲肠插管率、并发症和肠道准备质量。共有48759例患者接受了结肠镜检查,其中学术型医院34616例(80%),非学术型医院14143例。在这些病例中,检测到19942例(37.1%)高级别腺瘤和2607例(5.3%)结直肠癌(CRC),共计22549例(46.2%)高级别瘤变病例。腺瘤检出率为64%,学术型医院为63.1%,非学术型医院为66.4%(P<0.001)。高级别腺瘤检出率、盲肠插管率和充分结肠准备率分别为45.8%、96.2%和88.3%,在所有情况下,学术型医院的这些指标均较低(意味着医疗质量较差)(45.3%对48.7%;优势比[OR]0.87,95%置信区间[CI]0.84-0.91;95.9%对97%;OR 0.48,95%CI 0.38-0.69;86.4%对93%;OR 0.48,95%CI 0.45-0.5;所有情况下P<0.001)。13例患者(均在学术型医院组)在结肠镜检查后被诊断为CRC(0.26例/1000例结肠镜检查)。两种类型医院的内镜治疗CRC率相似(30%)。严重并发症发生率为1.2%(602例患者),不同医院类型之间无显著差异:每147例结肠镜检查中有1例发生出血,每329例中有1例发生穿孔。1例患者在筛查结肠镜检查后30天内死亡。非学术型医院的结肠镜检查质量更好。非学术型医院高级别瘤变的检出率更高,且与结肠镜检查后CRC的发生率相关。